Pre Clinical
Phase 1
Phase 2
Phase 3
Phase 4
Registration
- BioTheraMin ™
- BioTheraCin ™
- BioTheraCin ™
Executive Leadership & In House Drug Development Expertise
John Simon
CEO / Co-Founder
Alon Wolfman
President/ Interim CFO/Co-Founder
Christianne Street
CTO / Head of R&D
Luz Elana Parra
VP Operations
Sunny Dabas
Director of QA
Preeti Dabas
Director Operations
Korin Konidas
Director Regulatory
Brad Thompson
Corporate and Board Advisory
What we current have MANUFACTURE, IP, EXPERTISE
6500 sqft. facility licensed by Health Canada for:
Controlled Substances, Cannabis and Natural Health Products
4 Provisional Patents for Psilocybin formulations
1 Patent Application for novel natural psilocybin extraction process
3 Provisional Patents for Cannabinoid formulations